Abiopharma

U.S. FDA Grants Priority Review to sBLA for PADCEV + Keytruda as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Pediatrix Medical Group 2026 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 5, 2026

UTHR: United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026

Sable Offshore Corp. Provides Corporate Update

B2Gold Announces Agreement to Sell its 70% Interest in Fingold Joint Venture to Agnico Eagle for US$325 million; B2Gold and Agnico Eagle to Enter into Nunavut Collaboration Agreement

Shareholder Alert: Ademi LLP investigates whether TopBuild Corp. is obtaining a Fair Price for Public Shareholders

Daqo New Energy Files Annual Report on Form 20-F for Fiscal Year 2025

Supplementary report to the notice of a general meeting for May 5, 26

New International Banks Join Wallbox’s Financial Restructuring Plan

Silo Pharma Notification (SILO)